hematoxylin has been researched along with Neoplasms in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (30.56) | 18.7374 |
1990's | 2 (5.56) | 18.2507 |
2000's | 5 (13.89) | 29.6817 |
2010's | 9 (25.00) | 24.3611 |
2020's | 9 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ahmadvand, P; Bashashati, A; Boschman, J; Churg, A; Darbandsari, A; Farahani, H; Farnell, D; Gilks, CB; Huntsman, DG; Jones, SJ; Köbel, M; Levine, AB; Naso, JR; Van Spankeren, A; Yip, S | 1 |
Fu, Y; Gerstung, M; Gonzalez, S; Jimenez-Linan, M; Jung, AW; Moore, L; Shmatko, A; Torne, RV; Vöhringer, H; Yates, LR | 1 |
Jang, HJ; Lee, SH | 1 |
He, K; He, L; Jia, Y; Li, X; Liu, H; Lv, C; Qi, M; Qian, W; Wang, T; Wei, Z; Yan, W; Yu, F; Zhang, M; Zhao, L | 1 |
Bidgoli, AA; Campbell, CJV; Dehkharghanian, T; Mazaheri, P; Pantanowitz, L; Rahnamayan, S; Riasatian, A; Tizhoosh, HR | 1 |
Cui, D; Dou, W; Li, C; Wang, H; Yang, F | 1 |
Pedrosa, VF; Romano, LA | 1 |
de Faria, PR; do Nascimento, MZ; Martins, AS; Neves, LA; Roberto, GF; Servato, JPS; Tosta, TAA | 1 |
Gupta, R; Hou, L; Kurc, TM; Saltz, JH; Samaras, D; Sivalenka, K; Van Arnam, JS; Zhang, Y | 1 |
Bankhead, P; Boor, P; Brenner, H; Buelow, RD; Cipriani, NA; Echle, A; Grabsch, HI; Hanby, AM; Heij, LR; Hoffmeister, M; Jäger, D; Kather, JN; Kochanny, S; Kooreman, LFS; Krause, J; Loeffler, C; Luedde, T; Muti, HS; Niehues, JM; Ortiz-Brüchle, NN; Patnaik, A; Pearson, AT; Schulte, JJ; Sommer, KAJ; Speirs, V; Srisuwananukorn, A; Trautwein, C; van den Brandt, PA | 1 |
Adam-Granger, É; Albadine, R; Birlea, M; Gilks, B; Grosset, AA; Loayza-Vega, K; Nguyen, B; Soucy, G; Tran-Thanh, D; Trudel, D | 1 |
Jain, R; Jalay Meenai, F; Ojha, SS; Sawke, GK; Sawke, NG | 1 |
Ashton, K; Baker, MJ; Bonnier, F; Byrne, HJ; Davis, C; Dawson, T; Fullwood, LM; Griffiths, D; Lea, RW | 1 |
Kather, JN; Marx, A; Schad, LR; Schuster, AK; Weis, CA; Zöllner, FG | 1 |
Finotello, R; Ressel, L | 1 |
Bui, MM; Johnson, JO; Kasprzak, A; Lloyd, MC | 1 |
ROER, H | 1 |
Chang, PJ; Hung, MS; Jablons, DM; Lin, YC; Mao, JH; Xu, Z; Yang, CT; You, L | 1 |
Belicza, M | 1 |
Chen, SM; Ding, J; Geng, MY; Huang, X; Li, HL; Liu, HY; Liu, XF; Peng, T; Tong, LJ; Xie, H; Xin, XL; Yin, M | 1 |
Chiriboga, L; Diem, M; Lasch, P; Yee, H | 1 |
Bedolla, RG; Brattain, MG; Hidalgo, M; Kreisberg, JI; Malik, SN | 1 |
HORI, SH | 2 |
AZZOPARDI, JG; MOSTOFI, FK; THEISS, EA | 1 |
FROST, HM; VILLANUEVA, AR | 1 |
DERAZHNE, AB | 1 |
GIARDINI, RG | 1 |
Wittekind, D | 1 |
Koss, LG; Powell, GT; Yamase, HT | 1 |
Dill, PL; Macaluso, CK; Marsden, JA; Weisenthal, LM | 1 |
Yang, GC | 1 |
Futch, HN; Lambert, C | 1 |
Pengvanich, C; Srivannaboon, S | 1 |
Bodó, M; Péter, I; Sápi, Z; Sugár, J | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
5 review(s) available for hematoxylin and Neoplasms
Article | Year |
---|---|
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology.
Topics: Biomarkers, Tumor; Deep Learning; Eosine Yellowish-(YS); Hematoxylin; Humans; Neoplasms; Precision Medicine | 2022 |
Image Analysis of the Tumor Microenvironment.
Topics: Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Histological Techniques; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Neoplasms; Staining and Labeling; Tumor Microenvironment | 2016 |
[Evaluation of morphologically determined apoptotic index].
Topics: Apoptosis; Eosine Yellowish-(YS); Hematoxylin; Humans; Neoplasms; Staining and Labeling | 2009 |
Immunohistochemical determination of EGFR-tyrosine kinase inhibition in clinical samples.
Topics: Antineoplastic Agents; Biopsy; Enzyme Inhibitors; ErbB Receptors; Hematoxylin; Humans; Immunoenzyme Techniques; Neoplasm Proteins; Neoplasms; Paraffin Embedding; Phosphorylation; Protein Processing, Post-Translational; Specimen Handling; Staining and Labeling | 2003 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
31 other study(ies) available for hematoxylin and Neoplasms
Article | Year |
---|---|
The utility of color normalization for AI-based diagnosis of hematoxylin and eosin-stained pathology images.
Topics: Algorithms; Artificial Intelligence; Eosine Yellowish-(YS); Hematoxylin; Humans; Neoplasms; Staining and Labeling; United Kingdom | 2022 |
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis.
Topics: Deep Learning; Hematoxylin; Humans; Mutation; Neoplasms; Prognosis | 2020 |
Neospora caninum inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model.
Topics: Animals; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Cytokines; Eosine Yellowish-(YS); Hematoxylin; Immunity; Interleukin-10; Interleukin-12; Interleukin-2; Mice; Mice, Inbred C57BL; Neoplasms; Neospora; Propidium; RNA, Messenger; RNA, Ribosomal, 16S; Tumor Necrosis Factor-alpha | 2022 |
Biased data, biased AI: deep networks predict the acquisition site of TCGA images.
Topics: Coloring Agents; Eosine Yellowish-(YS); Hematoxylin; Humans; Neoplasms; Neural Networks, Computer | 2023 |
Application of ultrasonic cavitation combined with rapid pathological tissue processing method of novel environmental protection reagents in pathological diagnosis.
Topics: Conservation of Natural Resources; Eosine Yellowish-(YS); Formaldehyde; Hematoxylin; Humans; In Situ Hybridization, Fluorescence; Indicators and Reagents; Neoplasms; Tissue Fixation; Ultrasonics | 2023 |
Re-claiming H&E: back to the future.
Topics: Coloring Agents; Diagnosis, Differential; Eosine Yellowish-(YS); Hematoxylin; Histological Techniques; Humans; Inflammation; Neoplasms; Pathology, Clinical; Procedures and Techniques Utilization; Staining and Labeling | 2020 |
Unsupervised method for normalization of hematoxylin-eosin stain in histological images.
Topics: Color; Coloring Agents; Datasets as Topic; Eosine Yellowish-(YS); Hematoxylin; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Neoplasms; Staining and Labeling; Unsupervised Machine Learning | 2019 |
Dataset of segmented nuclei in hematoxylin and eosin stained histopathology images of ten cancer types.
Topics: Cell Nucleus; Eosine Yellowish-(YS); Hematoxylin; Histological Techniques; Humans; Image Processing, Computer-Assisted; Neoplasms | 2020 |
Pan-cancer image-based detection of clinically actionable genetic alterations.
Topics: Deep Learning; Eosine Yellowish-(YS); Hematoxylin; Humans; Mutation; Neoplasms | 2020 |
Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis.
Topics: Biomarkers, Tumor; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunohistochemistry; Male; Neoplasm Proteins; Neoplasms; Staining and Labeling | 2019 |
Role of Field Staining in the Cytological Assessment of Intraoperative Surgical Specimens.
Topics: Coloring Agents; Cytodiagnosis; Eosine Yellowish-(YS); Hematoxylin; Humans; Intraoperative Care; Lymph Nodes; Lymphatic Metastasis; Margins of Excision; Neoplasms; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Specimen Handling; Staining and Labeling | 2018 |
Effect of substrate choice and tissue type on tissue preparation for spectral histopathology by Raman microspectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Eosine Yellowish-(YS); Female; Hematoxylin; Histocytological Preparation Techniques; Humans; Male; Middle Aged; Neoplasms; Reference Standards; Spectrum Analysis, Raman; Staining and Labeling; Waxes | 2014 |
New Colors for Histology: Optimized Bivariate Color Maps Increase Perceptual Contrast in Histological Images.
Topics: 3,3'-Diaminobenzidine; Color; Coloring Agents; Hematoxylin; Histological Techniques; Humans; Image Processing, Computer-Assisted; Neoplasms; Staining and Labeling | 2015 |
Cytological grading of canine cutaneous mast cell tumours: is haematoxylin and eosin staining better than May-Grünwald-Giemsa?
Topics: Animals; Dog Diseases; Dogs; Eosine Yellowish-(YS); Hematoxylin; Mast Cells; Neoplasms; Staining and Labeling | 2017 |
A contribution to the histogenesis of ulcer carcinoma.
Topics: Hematoxylin; Humans; Neoplasms; Ulcer | 1948 |
Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
Topics: Adenosine Triphosphate; Apoptosis; Casein Kinase II; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; HCT116 Cells; HeLa Cells; Hematoxylin; Humans; Lung Neoplasms; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Substrate Specificity | 2009 |
Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors.
Topics: Animals; Antineoplastic Agents; Cations, Divalent; Cell Line; Cell Proliferation; Cloning, Molecular; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Hematoxylin; HL-60 Cells; Humans; Models, Molecular; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Receptor, IGF Type 1; Sensitivity and Specificity | 2011 |
Infrared spectroscopy of human cells and tissue: detection of disease.
Topics: Adenocarcinoma; Colon; Colonic Neoplasms; Coloring Agents; Diagnostic Techniques and Procedures; Eosine Yellowish-(YS); Epithelial Cells; Fluorescent Dyes; Hematoxylin; Humans; Male; Neoplasms; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Spectrophotometry, Infrared; Spectrum Analysis | 2002 |
Cytochemical studies on tumor cells. II. Localization of phospholipids in normal and neoplastic tissues, as revealed by the acid hematein test.
Topics: Hematoxylin; Neoplasms; Phospholipids | 1957 |
Cytochemical studies on tumor cells. III. Two types of tumor cells as revealed by the acid hematein test.
Topics: Hematoxylin; Humans; Neoplasms | 1957 |
Lesions of testes observed in certain patients with widespread choriocarcinoma and related tumors. The significance and genesis of hematoxylin-staining bodies in the human testis.
Topics: Choriocarcinoma; Female; Hematoxylin; Humans; Male; Neoplasms; Pregnancy; Staining and Labeling; Testis | 1961 |
A rapid method for obtaining hematoxylin and eosin biopsy sections of bone for table diagnosis.
Topics: Biopsy; Bone and Bones; Bone Neoplasms; Coloring Agents; Eosine Yellowish-(YS); Hematoxylin; Humans; Neoplasms; Staining and Labeling | 1961 |
[Intravital staining with hematoxylin in the clinical and histological diagnosis of the early stages of cancer of the cervix uteri. (Hemotoxylin test)].
Topics: Coloring Agents; Female; Hematoxylin; Humans; Neoplasms; Staining and Labeling; Uterine Cervical Neoplasms | 1960 |
[Cervical cancer; cytodiagnosis by means of smear with hematoxylin-eosin stain].
Topics: Cervix Uteri; Coloring Agents; Cytodiagnosis; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Neoplasms; Uterine Cervical Neoplasms | 1950 |
Traditional staining for routine diagnostic pathology including the role of tannic acid. 1. Value and limitations of the hematoxylin-eosin stain.
Topics: Animals; Coloring Agents; Eosine Yellowish-(YS); Hematoxylin; Humans; Hydrolyzable Tannins; Neoplasms; Staining and Labeling | 2003 |
A simplified method of preparing permanent tissue sections for the erythrocyte adherence test.
Topics: ABO Blood-Group System; Cell Adhesion; Eosine Yellowish-(YS); Erythrocytes; Fixatives; Glutaral; Hematoxylin; Humans; Immunologic Techniques; Neoplasm Invasiveness; Neoplasms; Polylysine; Staining and Labeling | 1981 |
A novel dye exclusion method for testing in vitro chemosensitivity of human tumors.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Doxorubicin; Drug Evaluation, Preclinical; Eosine Yellowish-(YS); Etoposide; Fluorouracil; Hematoxylin; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Melphalan; Neoplasms; Staining and Labeling | 1983 |
The mathematical basis for the increased sensitivity in cancer detection in air-dried cytopreparations.
Topics: Cell Nucleus; Cytodiagnosis; Desiccation; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Mathematics; Neoplasms; Pancreatitis-Associated Proteins; Sensitivity and Specificity; Specimen Handling; Staining and Labeling; Vaginal Smears | 1994 |
An evaluation of elastic tissue staining.
Topics: Aldehydes; Aorta; Elastic Tissue; Female; Hematoxylin; Histological Techniques; Humans; Lung; Neoplasms; Rosaniline Dyes; Skin; Staining and Labeling; Uterus | 1976 |
The application of toluidine blue staining in non-gynecologic cytology.
Topics: Cytological Techniques; Evaluation Studies as Topic; Female; Hematoxylin; Humans; Neoplasms; Papanicolaou Test; Sensitivity and Specificity; Tolonium Chloride; Vaginal Smears | 1992 |
[Immunoperoxidase reactions in cytological aspiration smears previously stained with hematoxylin-eosin].
Topics: Benzopyrans; Biopsy, Needle; Eosine Yellowish-(YS); Hematoxylin; Humans; Immunoenzyme Techniques; Melanoma; Neoplasm Metastasis; Neoplasms; Staining and Labeling | 1988 |